IDO1 and delirium: The Kyn pathway of Trp metabolism, induced by immunological activation (IDO) and stress (TDO), generates several neuroactive compounds (QA, KynA) and can thus uniquely modulate several cognitive disorders, affecting the development of delirium in critically ill patients.